Abstract
A series of 4-(7,7-dimethyl-4-(piperazin-1-yl)-5,6,7,8-tetrahydroquinazolin-2-yl)morpholine substituted sulfonamide and urea derivatives has been synthesized and characterized using spectral techniques. The antiviral activity of these compounds against an avian paramyxo virus (AMPV-1) was screened using MTT assay and found that one of the sulfonamide derivatives (2d) show three-fold higher antiviral activity than Ribavirin, a commercial antiviral drug substance.
Graphical abstract
Similar content being viewed by others
References
Cano C, Barbeau OR, Bailey C, Cockcroft XL, Curtin NJ, Duggan H, Frigerio M, Golding BT, Hardcastle IR, Hummersone MG, Knights C, Menear KA, Newell DR, Richardson CJ, Smith GCM, Spittle B, Griffin RJ (2010) DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype. J Med Chem 53(24):8498–8507
Cano C, Saravanan K, Bailey C, Bardos J, Curtin NJ, Frigerio M, Golding BT, Hardcastle IR, Hummersone MG, Menear KA, Newell DR, Richardson CJ, Shea K, Smith GC, Thommes P, Ting A, Griffin RJ (2013) 1-Substituted (dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity. J Med Chem 56(16):6386–6401
Chou T, Li K, Frankowski KJ, Schoenen FJ, Deshaies RJ (2013) Structure–activity relationship study reveals ML240 and ML241 as potent and selective inhibitors of p97 ATPase. Chem Med Chem 8(2):297–312
de Boer D, Bosman IJ, Hidvegi E, Manzoni C, Benko AA, dos Reys LJ, Maes RA (2001) Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. Forensic Sci Int 121(1-2):47–56
Dibyendu D, Khanna IK, Pillarisetti S (2010) Novel bicyclic compounds as GATA modulators. WO028174(A1):1–135
Dmitriy Z, Peter P (2012) Oncolytic newcastle disease virus for cancer therapy: old challenges and new directions. Future Microbiol 7(3):347–367
Fackler JC, Flannery K, Zipkin M, McIntosh K (1990) Precautions in the use of ribavirin at the children’s hospital. N Engl J Med 322(9):634
Gerlier D, Thomasset N (1986) Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 94(1-2):57–63
Gilbert BE, Knight V (1986) Biochemistry and clinical applications of ribavirin. Antimicrob Agents Chemother 30:201–205
Hebert MF, Guglielmo BJ (1990) What is the clinical role of aerosolized ribavirin? Drug Intell Clin Pharm 7-8:735–738
Hepworth JD, Gabbutt CD, Heron BM (Eds.) (1995) Comprehensive heterocyclic chemistry-II. Pergamon Press, Oxford, p 221
Izuru A, Tsuyoshi A, Naoki O, Yukiyo T, Kazuyuki S, Hiroyuki A, Masafumi K, Toru N (2012) Preclinical characterization of JTK-853, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase. Antimicrob Agents Chemother 56(8):4250–4256
John RK, Huaqing L, Irene D, David GW, Tracy LC, Arlene MM, Lvan M, Marina IS, Thomas RM, Timothy AE, Jorge DB, Marlon C (2010) Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ring. Biorg Med Chem Lett 20(6):1900–1904
Joule JA, Mills K (2008) Heterocyclic chemistry. Wiley, New York, NY
Katritzky AR, Rees CW, Hepworth JD (Eds.) (1985) Comprehensive heterocyclic chemistry. Pergamon Press, Oxford, p 150
Kengi M, Takashi S, Takao N, Michio I, Neill AG, Jin-Chen Y, Shogi O, Yuji N (2003) Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. Part 4: structure–activity relationships for substituents on the quinazoline moiety of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives. Biorg Med Chem Lett 13(18):3001–3004
Kobayashi J, Kand F, Ishibashi M, Shigemori H (1991) Manzacidins A–C, novel tetrahydropyrimidine alkaloids from the Okinawan marine sponge hymeniacidon sp. J Org Chem 56(14):4574–4576
Looper RE, Runnegar MTC, Williams RM (2005) Synthesis of the putative structure of 7-deoxycylindrospermopsin: C7 oxygenation is not required for the inhibition of protein synthesis. Angew Chem Int Ed 25(44):3879–3881
Noronha G, Cao J, Gritzen C, Mak C, McPherson A, Pathak VP, Renick J, Soll RM, Zeng B, Dneprovskaia E (2008) 2-amino-5-substituted pyrimidine inhibitors. US Patent 0027070:1–99
Ravindra PV, Ashok KT, Bhaskar S, Chauhan RS (2009) Newcastle disease virus as an oncolytic agent. Indian J Med Res 130:507–513
Scozzafava A, Owa T, Mastrolorenzo A, Supuran CT (2003) Anticancer and antiviral sulfonamides. Curr Med Chem 10(11):925–953
Sekiya T, Hiranuma H, Kanayama T, Hata S (1980) Pyrimidine derivatives I. Synthesis of hypoglycemic 2-piperazino-5,6-polymethylenepyrimidines 5,6-polymethylenepyrimidines. Eur J Med Chem 15(4):317–322
Selvakumar B, Vaidyanathan SP, Madhuri S, Elango KP (2017) Synthesis and antiviral activity of 4-(7,7-dimethyl-4-[4-{N-aroyl/benzyl}1-piperazinyl]-5,6,7,8-tetrahydroquinazolin-2-yl) morpholine derivatives. Arkivoc iv:353–364
Skinner GS, Wunz PR (1951) 2,5,5-Trialkyl-1,4,5,6-tetrahydropyrimidines. J Am Chem Soc 73(8):3814–3815
Sudhakar Babu K, Ravindranath KL, Latha J, Prabhakar V (2015) Synthesis, characterization and mass analysis of novel tri substituted quinazoline-urea derivatives bearing trans substituted morpholine and azetidinone moieties. Int J Pharm Res Rev 4(1):364–380
Supuran CT, Innocenti A, Mastrolorenzo A, Scozzafava A (2004) Antiviral sulfonamide derivatives. Mini Rev Med Chem 4(2):189–200
Suresh Kumar K, Swastika G, Ravichandran V, Vijayapandi P (2014) Synthesis, antiviral and antimicrobial activities of quinazoline urea analogs. Int J Drug Des Discov 4(4):1215–1230
Tetsuo S, Hidetoshi H, Masayuki U, Shunsuke H, Shun-Ichi Y (1981) Pyrimidine deivatives II. New synthesis and reactions of 4-amino-2-methylthiopyrimidine derivatives. Chem Pharm Bull 29(4):948–954
Acknowledgements
We are thankful to the Management, Anthem Biosciences, Bangalore, India, for their invaluable support and allocation of resources for this work. We would like to thank the Analytical Chemistry team of Anthem Biosciences for having carried out all the analytical work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Selvakumar, B., Gujjar, N., Subbiah, M. et al. Synthesis and antiviral study of 4-(7,7-dimethyl-4-(piperazin-1-yl)-5,6,7,8-tetrahydroquinazolin-2-yl) morpholine derivatives. Med Chem Res 27, 512–519 (2018). https://doi.org/10.1007/s00044-017-2077-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-017-2077-5